Science Explorer Back to mapMap
Discussion
Researcher · Biopticka Laborator (Czechia) · Czechia

Monika Šedivcová

Monika Šedivcová publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Colorectal Cancer Treatments and Studies.

OpenAlex
World rank
#3,865,024
of 7,710,434 ranked researchers
Rank in Czechia
#11,268
of 39,303
Works
28
Citations
695
Citations per work
24.8
h-index
12
i10-index 12Top 48% in Oncology
Monika Šedivcová

What does Monika Šedivcová research?

Monika Šedivcová's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (5%), Immunology and Microbiology (5%).

Health Sciences: 16 works · 56.4% of their workMedicine: 16 works · 56.4% of their workOncology: 6 works · 21.3% of their workPulmonary and Respiratory Medicine: 5 works · 16.3% of their workSurgery: 4 works · 12.5% of their workGastroenterology: 2 works · 6.3% of their workEverything else: 9 works · 33.6% of their workLife Sciences: 3 works · 10.0% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 5.0% of their workCancer Research: 1 works · 5.0% of their workImmunology and Microbiology: 1 works · 5.0% of their workImmunology: 1 works · 5.0% of their workTHEIR WORKMonika Šedivcová28works
Life Sciences10%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1656.4%
  2. Everything else933.6%
    1. Biochemistry, Genetics and Molecular Biology15.0%
    2. Immunology and Microbiology15.0%
  1. 1Oncology21% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Surgery12% of their works
  4. 4Gastroenterology6% of their works
  5. 5Cancer Research5% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Monika Šedivcová's research?

The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Immunotherapy, Molecular Characterization, Treatment, Osteosarcoma, Soft Tissue Sarcoma and Cetuximab.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Prognostic Factors194 topics
  2. Chemotherapy184 topics
  3. Immunotherapy92 topics
  4. Molecular Characterization92 topics
  5. Treatment82 topics
  6. Osteosarcoma61 topic
  7. Soft Tissue Sarcoma61 topic
  8. Cetuximab51 topic
  9. Imatinib Mesylate51 topic
  10. KRAS Mutations51 topic
  11. Metastatic51 topic
  12. Renal Cell Carcinoma51 topic
  13. Sunitinib51 topic
  14. Hereditary Syndromes41 topic
  15. Microsatellite Instability41 topic
  16. Pancreatic Cancer41 topic
  17. Surgical Complications41 topic
  18. Desmoid Tumor31 topic
  19. Germ Cell Tumors31 topic
  20. Solitary Fibrous Tumor31 topic
  21. Testicular Cancer31 topic

Where does Monika Šedivcová work?

Monika Šedivcová's main affiliation in the publication record is Biopticka Laborator (Czechia), Czechia.

How many publications and citations does Monika Šedivcová have?

OpenAlex counts 28 works and 695 citations for Monika Šedivcová, an h-index of 12, ranking #3,865,024 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Monika Šedivcová. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.